Amwell Q2 FY26 net loss narrows to $9.63 million; revenue falls to $52.05 million
AMWL•Outlook raised for 2026 and Q3
- Raised 2026 revenue outlook to $200 million-$205 million.
- Q3 revenue seen at $46 million-$48 million.
Q2 results show narrower loss and lower revenue
- American Well posted Q2 revenue of $52 million, down 26.58% year over year, with subscription revenue of $25.7 million.
- Net loss narrowed to $9.6 million; loss per share improved to $0.59.
- Gross margin was 53%; adjusted EBITDA loss (non-GAAP) narrowed to $1.2 million from $3.1 million in Q1 2026.
- Total visits were 800,000; CEO Ido Schoenberg cited DHA’s intent to make Amwell a prime contractor.
